联合检测血清25羟基维生素D及肿瘤标志物在结直肠癌诊断中的应用

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

联合检测血清25羟基维生素D及肿瘤标志物在结直肠癌诊
断中的应用
杨晓云;刘蕊
【期刊名称】《中国中西医结合外科杂志》
【年(卷),期】2016(022)005
【摘要】Objective To investigate the value of combined detection of serum 25(OH)D and tumor mark⁃ers in the diagnosis of colorectal cancer (CRC). Methods Serum levels of 25(OH)D, CEA, and CA19-9 were detected in 150 healthy controls and 150 cases of CRC patients. Clinical data and laboratory indexes of recruit⁃ed subjects and pathological data of CRC patients were collected. Results Serum levels of 25(OH)D in pa⁃tients with CRC (33.17 ± 15.75 nmmol/L) was lower than that in healthy controls (41.18 ± 11.59 nmmol/L),P<0.01. CEA and CA19-9 in patients with CRC [3.67(2.14,7.20) ng/mL、8.10(3.10,18.90) U/mL] were higher than those in healthy control [2.26(1.75,3.09) ng/mL、4.82(2.90,7.35) U/mL],P<0.01. Serum 25 (OH) D and CEA in patients with CRC have poor consistency (Kappa=0.174, P<0.05). Serum CEA levels of CRC patients with non-ulcer, high and middle cell differentiation, clinical stage ofⅠ~Ⅱ period and without lymph node metasta⁃sis, were significantly lower than that of CRC patients with ulcer, poorly cell differentiation, the clinical stage ofⅢ~Ⅳ period and lymph node metastasis(P<0.05), but serum 25(OH)D levels in all groups showed no statisti⁃cal difference (P>0.05). Conclusion Combined
detection of 25(OH)D, CEA and CA19-9 may has clinical application value for early diagnosis, recurrence, metastasis and prognosis of CRC.%目的:探讨联合检测血清25羟基维生素D[25(OH)D]及肿瘤标志物在结直肠癌(CRC)诊断中的应用价值。

方法:检测150例正常对照者及150例CRC患者血清
25(OH)D、CEA、CA19-9等指标;收集CRC患者肿瘤临床病理特征资料,进行统计分析。

结果:CRC患者血清25(OH)D水平[(33.17±15.75)nmmol/L]低于正常对照者[(41.18±11.59)nmmol/L],P<0.01;CEA及CA19-9水平[分别为3.67(2.14,7.20) ng/mL、8.10(3.10,18.90) U/mL],高于正常对照者[分别为2.26(1.75,3.09) ng/mL、4.82(2.90,7.35) U/mL],P<0.01;CRC患者血清
25(OH)D及CEA水平一致性较差,(Kappa=0.174,P<0.05);肿瘤大体类型为非溃疡型、细胞为高中分化、临床分期为Ⅰ~Ⅱ期及无淋巴结转移的CRC患者血清CEA水平均低于大体类型为溃疡型、肿瘤细胞为低分化、临床分期为Ⅲ-Ⅳ期及发生淋巴结转移者(P<0.05),但血清25(OH)D水平在各组间的比较均未见统计学差异(P>0.05)。

结论:联合检测患者血清25(OH)D与肿瘤标志物浓度,对早期诊断CRC及评估病情具有临床应用意义。

【总页数】5页(P445-449)
【作者】杨晓云;刘蕊
【作者单位】天津市人民医院检验科天津 300191;天津市人民医院检验科天津300191
【正文语种】中文
【中图分类】R735.3
【相关文献】
1.血脂水平与血清肿瘤标志物联合检测在结直肠癌诊断中的应用价值 [J], 杨创杰
2.联合检测血清肿瘤标志物CEA、CA199、CA242及CA724在结直肠癌诊断中的应用 [J], 宋培栋;翟根成
3.血清25羟基维生素D及肿瘤标志物联合诊断乳腺恶性肿瘤的价值研究 [J], 桂凌;陈亚军;高玲娟;曾玉
4.肿瘤标志物联合25羟基维生素D诊断结直肠癌的价值 [J], 雷凯; 高校奇; 金雷; 祁亚斌
5.联合检测血清25羟基维生素D与肿瘤标志物诊断结直肠癌的临床意义 [J], 朱宏财;薛辉;薛玲;王莹;庞琼;侯新丽;岳丽娟
因版权原因,仅展示原文概要,查看原文内容请购买。

相关文档
最新文档